Chudnovsky Yekaterina Insider Trades

Insider Trading History

Track insider trading activity for Chudnovsky Yekaterina. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Immix Biopharma
Immix Biopharma IMMX
Director
Holding Value $124k 12,500 shares
Last Trade
May 22, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$165k 18,750 shares
$8.78
$9.91
Immix Biopharma
Immix Biopharma IMMX
10% owner
Holding Value $327k 33,000 shares
Last Trade
Jun 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$73.9k 33,000 shares
$2.24
$9.91
Elicio Therapeutics
Elicio Therapeutics ELTX
10% owner
Holding Value $424k 103,225 shares
Last Trade
Jun 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$800k 103,225 shares
$7.75
$4.11
Elicio Therapeutics
Elicio Therapeutics ELTX
10% owner
Holding Value $32.5k 7,900 shares
Last Trade
May 19, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$46.1k 7,900 shares
$5.84
$4.11
Elicio Therapeutics
Elicio Therapeutics ELTX
10% owner
Holding Value $22.3M 5,416,212 shares
Last Trade
Mar 05, 2025 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$28.9M 3,500,573 shares
$8.27
$4.11
Elicio Therapeutics
Elicio Therapeutics ELTX
10% owner
Holding Value $0 0 shares
Last Trade
Mar 05, 2025 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$28.5M 3,442,341 shares
$8.27
$4.11
Elicio Therapeutics
Elicio Therapeutics ELTX
10% owner
Holding Value $16.9k 4,100 shares
Last Trade
Nov 21, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$21k 4,100 shares
$5.12
$4.11
Elicio Therapeutics
Elicio Therapeutics ELTX
10% owner
Holding Value $14.1M 3,442,341 shares
Last Trade
Aug 12, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$14.9M 3,442,341 shares
$4.32
$4.11
Elicio Therapeutics
Elicio Therapeutics ELTX
10% owner
Holding Value $6.58M 1,600,000 shares
Last Trade
Jun 28, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$13.2M 3,200,000 shares
$4.11
$4.11
Immix Biopharma
Immix Biopharma IMMX
10% owner
Holding Value $327k 33,000 shares
Last Trade
Jun 11, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$67.3k 33,000 shares
$2.04
$9.91
Elicio Therapeutics
Elicio Therapeutics ELTX
10% owner
Holding Value $4.24M 1,032,702 shares
Last Trade
Mar 19, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.58M 1,032,702 shares
$6.37
$4.11
Elicio Therapeutics
Elicio Therapeutics ELTX
10% owner
Holding Value $16.9k 4,100 shares
Last Trade
Dec 28, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$33.9k 4,100 shares
$8.26
$4.11
Angion Biomedica
Angion Biomedica ANGN
10% owner
Holding Value $4.1k 4,100 shares
Last Trade
Dec 28, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$410k 4,100 shares
$100.00
$1.00
Elicio Therapeutics
Elicio Therapeutics ELTX
10% owner
Holding Value $7.87M 1,915,639 shares
Last Trade
Dec 22, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$7.05M 1,213,000 shares
$5.81
$4.11
Angion Biomedica
Angion Biomedica ANGN
10% owner
Holding Value $1.92M 1,915,639 shares
Last Trade
Dec 22, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$121M 1,213,000 shares
$100.00
$1.00
Immix Biopharma
Immix Biopharma IMMX
10% owner
Holding Value $198k 20,000 shares
Last Trade
Aug 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$66k 36,670 shares
$1.80
$9.91
Angion Biomedica
Angion Biomedica ANGN
Director
Holding Value $0 0 shares
Last Trade
Jun 01, 2023 Sale
$453k 4,525 shares
$100.00
$1.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up